A comprehensive view of Oral Medicines / Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published: April 24, 2024 by CE Noticias Financieras (Latin America)
KORSCH America receives an Exhibitor Award at INTERPHEX NYC for their recently launched X 5 Tablet Press; the press is designed for increased single-sided output and flexibility in high-volume environments
Published: April 24, 2024 by WhatTheyThink
Vanda Pharmaceuticals' attempts to uphold patents for circadian rhythm drug Hetlioz denied by the US Supreme Court; the decision follows an earlier legal loss against generic drug manufacturers Teva and Apotex & an FDA rejection of Hetlioz usage expansion
Published: April 23, 2024 by FiercePharma
Sanofi's rilzabrutinib meets primary endpoint in Phase 3 LUNA 3 study for immune thrombocytopenia; potential for clinically beneficial treatment of several immune diseases underscored, with regulatory submissions in the US and EU expected by year-end
Published: April 23, 2024 by Sanofi SA
Vanda Pharmaceuticals thwarts a hostile takeover bid from Future Pak by implementing a shareholder rights plan or 'poison pill' strategy; the bid follows FDA approval for the expansion of its antipsychotic drug Fanapt
Published: April 19, 2024 by FiercePharma

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count